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PURPOSE. The purpose of this study was to develop a murine model of allergic conjunctivitis
induced by house dust mite (HDM) extract from Dermatophagoides pteronyssinus, a major
allergen in humans.
METHODS. Forty BALB/c mice were divided into five groups, immunized with placebo,
ovalbumin (10 lg), or HDM extract following a schedule. Twenty minutes after topical
challenge, mice were examined clinically. Material collected from mice was used for
measuring total and specific IgE, antigen-specific lymphocyte proliferation, and supernatant
cytokine levels and for conjunctival histopathology and flow cytometric analysis of
conjunctival cells.
RESULTS. This murine model showed similar clinical signs and laboratory findings to human
allergy and the ovalbumin-induced allergic conjunctivitis model. Total IgE levels and
conjunctival infiltration of mast cells and eosinophils in immunized mice were significantly
higher than in the control group. Cervical lymphocyte proliferation was increased in antigen-
stimulated cultures in immunized mice, concomitant with significantly higher IL-4 and IL-5
levels in the culture supernatant. The proportion of conjunctival CD4þ T cells expressing the
ST2 receptor was increased, and conjunctival CD4þST2þ T cells exhibited an increase in
intracellular IL-5.
CONCLUSIONS. House dust mite extract successfully induced allergic conjunctivitis in BALB/c
mice. Ten micrograms of HDM extract was the optimal dose for systemic immunization in this
model. This murine model is suitable for further studies on HDM-induced allergic
conjunctivitis, and the data show that conjunctival CD4þ T cells expressing ST2 may play
an important role in IL-5 secretion, recruiting eosinophils into conjunctiva on ocular allergen
challenge.
Keywords: allergic conjunctivitis, house dust mite, Dermatophagoides pteronyssinus, IL-4,
IL-5, ST2
Ocular allergy is a common ocular immune disorder, and theincidence and prevalence of allergic conjunctivitis has
increased dramatically all over the world, especially in
westernized nations.1,2 Allergic conjunctivitis is commonly
combined with other allergic diseases such as allergic rhinitis,
atopic dermatitis, and allergic asthma.3 The allergic reactions
result from IgE or T cell–mediated reactions. After cross-linking
between the antigen and antigen-presenting cell is complete,
dendritic cells (DCs) activate T helper (Th)2 cells, which results
in the release of IL-4 (important to IgE synthesis) and IL-5
(important to eosinophil recruitment). Interleukin-4 regulates
differentiation of na¨ıve Th0 cells to antigen-specific Th2 cells,
which then release IL-4, 5, 9, and 13 and stimulate IgE
production by B cells. In allergic conjunctivitis, provocation of
conjunctiva by allergen induces immigration of mature DCs via
lymphatic vessels from allergen-exposed tissues to the cervical
lymph node, promoting Th2 activation, resulting in increased
conjunctival infiltration of mast cells and eosinophils producing
various inflammatory cytokines that make an altered inflamma-
tory tear film.4,5 Recent studies have highlighted the immune-
modulatory role of the conjunctival epithelium and goblet cells
to allergic conjunctivitis and costimulation of DC–T-cell
interaction via chemokine (C-C motif) receptor (CCR) 7.6
Clinically, the symptom of allergic conjunctivitis is charac-
terized by itching, lid swelling, conjunctival redness, foreign
body sensation, stinging eyeball pain, and excessive tearing.1,7
Seasonal allergic conjunctivitis (SAC) and perennial allergic
conjunctivitis (PAC) are two allergic conjunctival disorders that
are predominantly caused by a mast cell–mediated hypersen-
sitivity reaction to airborne or exposed allergens.1 Atopic
keratoconjunctivitis and vernal keratoconjunctivitis can be-
come quite severe, leading to corneal involvement and rarely
can lead to blindness.7 Perennial allergic conjunctivitis is a
chronic condition, which usually involves sensitization to
allergens that are present year-round, such as house dust mites
(HDMs), animal dander, molds, and air pollutants, and shows
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more eosinophil infiltration in conjunctiva compared with that
in SAC.8 Perennial allergic conjunctivitis is commonly due to an
allergy to HDMs, which is sometimes related to atopic
keratoconjunctivitis,9 and most patients have specific serum
IgE for HDM.1 Perennial allergic conjunctivitis can induce mast
cell and eosinophil infiltration into the conjunctiva, and an
altered, inflammatory tear film resulted from chronic inflam-
mation of the ocular surface would not provide a sufficient
ocular surface, thereby compromising the defense system and
decreasing the threshold for an allergen attack.7
House dust mites, commonly found in human dwellings, are
an important source of inhalant and contact allergens. The
sensitization rate to HDMs has increased in South Korea with
industrialization and westernization.10 In South Korea, Derma-
tophagoides farina and Dermatophagoides pteronyssinus are
the most common HDM species.10,11 The D. pteronyssinus Der
p1 and Der p2 protein allergens are associated with 40%–60%
of total immunity.12
A reliable animal model of allergic conjunctivitis using
diverse allergens similar to the human equivalent is needed to
delineate the pathophysiologic and immunologic mechanism
of ocular allergic inflammation and to develop novel therapeu-
tic strategies. To date, animal models of allergic conjunctivitis
have been developed using limited allergens like ovalbumin,
ragweed pollen, and cat allergen in guinea pigs, rats, and
mice.13 In contrast, reports on animal models aiming at
understanding PAC such as HDM-induced allergic conjunctivi-
tis are rare.9,14,15 Hara et al.9 developed atopic keratoconjunc-
tivitis in an NC/Nga mouse model using D. farina. They
applied dermatologic ointment with 5 mg D. farina used for
skin sensitization without an adjuvant several times for 17 days
and applied topical ophthalmic ointment or solution including
allergen extracts of D. farina every 3 days. This is a novel
murine atopic keratoconjunctivitis model, but for inducing an
allergic condition, it needs a considerable supply of HDM
extracts.
We developed a murine model of allergic conjunctivitis in
Balb/c mice using an extract from a different Dermatophagoi-
des species, D. pteronyssinus, which is an important source of
major allergens of PAC. We used different concentrations of the
allergen, because the allergen concentration is an important
determinant of the allergic reaction, such that excess amounts
of the allergen activate T-suppressor cells that result in
suppression of the immune reaction.7,16,17 We also performed
flow cytometric analysis, serum IgE measurements, and
conjunctival histopathologic assessments.
Recent studies suggest an important role for the IL-33–ST2
interaction in allergic diseases.6,18–24 Epithelial cell–derived IL-
33, induced by airborne allergens, viruses, and air pollutants, is
known to activate na¨ıve and Th2 lymphocytes, mast cells, and
eosinophils and promotes Th2-type cytokine production via a
ST2, a membrane-bound IL-33–specific receptor expressed on
mast cells, Th2 cells, and eosinophils.20 Therefore, we evaluated
whether conjunctival CD4þ T cells in our murine model of
allergic conjunctivitis expressed ST2 and produced IL-5 on
repeated allergen challenge. The murine model developed in
this study presented clinical signs and histopathologic and
molecular features of allergic conjunctivitis in humans and can
be used to delineate the pathophysiologic mechanism of ocular
allergy and in development of therapeutic strategies.
MATERIALS AND METHODS
Experimental Animals
Forty female 8-week-old BALB/c mice were housed in a
pathogen-free environment at Yonsei University Animal Center.
The study protocol was approved by the Animal Experiments
Ethics Review Committee of Yonsei University, College of
Medicine, Seoul, Korea. All procedures were carried out in
accordance with the ARVO statement for the Use of Animals in
Ophthalmic and Vision Research.
Reagents
The sensitization and challenge agents included ovalbumin
(OVA; Grade V; Sigma-Aldrich Corp., St. Louis, MO, USA), HDM
extract from D. pteronyssinus, and aluminum hydroxide
(ALUM; Imject Alum; Thermo Scientific, Inc., Rockford, IL,
USA). Lyophilized powder of HDM extract from D. pteronyssi-
nus was purchased from the Internal Medicine Department,
College of Medicine, Yonsei University. Major HDM extract
allergen concentrations were 24.0 lg/mg (11.6 lg/mg of Der
p1 and 12.4 lg/mg of Der p2), as assessed using two-site ELISA
after reconstitution of lyophilized powder to 1 mg/mL in
PBS.25 Chloramphenicol inhibition assays showed that the
allergen concentrations in the HDM extract were 12.8 AU/lg.25
Experimental Allergic Conjunctivitis
Forty mice were divided into five groups (eight mice per
group) and allergen-sensitized following protocols developed
in our laboratory (Supplementary Fig. S1). Control mice were
sensitized by an intraperitoneal injection of 0.2 mL PBS and
ALUM (2.0 mg) on days 1 and 8. They were challenged by
topical instillation of 5 lL PBS in each eye on days 15, 17, and
19. Mice in the OVA group were sensitized by intraperitoneal
injection of 0.2 mL OVA (10 lg) absorbed on ALUM (2.0 mg),
and 5 lL 5% OVA (250 lg OVA absorbed in PBS) was used for
topical instillation on the scheduled days, as described
previously.26
The mice in the three HDM groups were sensitized by
intraperitoneal injection with different concentrations of
allergen (0.2 mL of 10, 100, or 500 lg of HDM extract,
respectively) absorbed on ALUM (2.0 mg). They were
challenged by topical instillation of 5 lL of 10% HDM (500
lg HDM absorbed in PBS).
On day 19, clinical symptoms and signs in anesthetized
mice were investigated 20 minutes after ocular allergen
challenge. On day 20, mice were killed, and serum and
cervical lymph node samples, whole eyeballs, including upper
and lower eyelids, and conjunctival tissue samples were
collected for further analyses.
Evaluation of Symptoms and Signs
On day 19, mice were assessed for clinical symptoms and signs
of an immediate hypersensitivity response 20 minutes after the
ocular challenge under respiratory anesthesia by an indepen-
dent observer blinded to the grouping. The symptoms of the
mice in the cage, eye frowning, tearing/discharge, chemosis,
hyperemia, and eyelid edema, were graded from 0 to 2
according to severity (0, no finding; 1, mild; 2, severe; Table
1).27 The category ‘‘Behavior’’ including face washing, eye
frowning, agitation, and lethargy/crouching can be considered
reflections of severe ocular discomfort and stimulation during
the acute-phase response (0, none of them; 1, one item among
them; 2, more than two items among them; Fig. 1). The grades
for each of the six parameters were added to obtain a total
clinical score of between 0 and 12, proportional to the
symptom intensity. Images of the eyes of the mice were also
captured.
Twenty-four hours after the ocular allergen challenge of
immunized mice, animals were anesthetized, and blood was
collected through cardiac puncture. Cervical lymph node
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dissection and eyeball enucleation were carried out. Then,
total and specific IgE levels were measured, and assays of HDM-
specific lymphocyte proliferation and supernatant cytokine
levels and histopathologic evaluation of the conjunctiva were
performed.
Measurement of Total and HDM-Specific IgE Levels
Total and HDM-specific IgE antibodies in serum samples were
measured using ELISA.28 Briefly, 96-well Maxi-Sorp plates
(Nunc; VWR Canlab, Mississauga, ON, Canada) were coated
with 100 lL purified rat anti-mouse IgE antibodies (2 lg/mL;
R35-72; BD Biosciences Pharmigen, San Diego, CA, USA) for
total IgE antibody detection overnight at 48C, and other plates
were coated with 100 lL HDM extract (50 lg/mL in PBS) for
HDM-specific IgE antibody detection overnight at 48C. After
blocking with 1% BSA in PBS for 1 hour at 378C, serial dilutions
of serum samples and standard mouse IgE antibodies (27-74;
BD Pharmigen) were added, and the mixtures were incubated
overnight at 48C. The plates were then washed with PBS
containing 0.05% Tween (PBS/T) and incubated with 100 lL
horseradish peroxidase–conjugated rat anti-mouse IgE anti-
body (2 lg/mL; Southern Biotech, Birmingham, AL, USA) for 2
hours at 378C.
After washing with PBS/T, samples were treated with
tetramethyl-benzidine (Moss, Inc., Pasadena, CA, USA) for 15
minutes at room temperature, and the chromogenic reaction
was stopped by adding 0.5 N HCI. The absorbance at 450 nm
was measured, and total IgE concentrations were calculated,
using the linear range of a standard of curve generated with
purified mouse IgE antibody (27-74; BD Pharmingen). As no
HDM-specific IgE standards exist, values were expressed in
units of optical density (OD) at 450 nm.
Allergen-Specific Lymphoid Cell Proliferation in
Cervical Lymph Node
Cervical lymph node cells were mashed in RPMI 1640 medium
(Gibco, Carlsbad, CA, USA) supplemented with 10% heat-
inactivated fetal calf serum, penicillin (50 U/mL), streptomycin
(50 lg/mL), and 2 mM L-glutamine, and the dispersed cells
were filtered through a 100-lm strainer to obtain a single-cell
suspension. Cells were reconstituted to a concentration of 43
106 cells/mL, with a final volume of 0.1 mL/well. For evaluation
of antigen-specific lymphocyte proliferation, cervical lymphoid
cells were cultured in U-bottomed 96-well immunoplates
(Nunc), with or without stimulation, using 100 lg/mL HDM
or 1 mg/mL OVA for 72 hours.
After culture, proliferation and cell cycle phase distribution
of lymphocytes were assessed using a bromodeoxyuridine
(BrdU) ELISA kit (BD Biosciences, San Jose, CA, USA). Levels of
TNF-a, IFN-c, IL-2, IL-4, and IL-5 in the culture supernatant
were measured using ELISA kits (BD Cytometric Bead Array
Mouse Th1/Th2 cytokine kit; BD Biosciences). Flow cytometry
was performed with the FACSCalibur system (BDTM FACS LSR
II; BD Biosciences).
Histopathology
To evaluate the cellular infiltrates in conjunctiva during the
late-phase reaction, the left eyes of the mice were used for
histopathologic analysis. Whole eye tissue, including eyeballs,
upper and lower eyelids, and the bulbar conjunctiva, were
harvested 24 hours after the final topical challenge and fixed in
4% buffered formalin. Samples were embedded in paraffin and
then vertically sectioned in 4-lm-thick planes of the central
lesion. Samples were stained with hematoxylin-eosin for
evaluation of general pathologic changes and with toluidine
blue stain for analysis of mast cells. Fields from each sample,
including the palpebral and bulbar conjunctiva, were exam-
ined under a light microscope (Olympus; Olympus Optical Co.
Ltd., Tokyo, Japan) at 3400 magnification. Eosinophils were
identified as cells in which the cytoplasmic granules were
stained with eosin. An observer masked to the origin of the
slides counted the infiltrating eosinophils and mast cells. A
total of eight sections representing the central portion of
samples from each group were counted, and the data are
presented as the mean 6 SD.
Quantitative Analysis of CD4þ T Lymphocytes in
Conjunctiva
For quantitative analysis of CD4þ T lymphocytes in conjunctiva,
bulbar and palpebral conjunctival tissues were separated
carefully from enucleated right eye tissues in the control, OVA,
and HDM (10 lg) groups. The conjunctiva were sliced and
incubated in complete medium supplemented with 5 mg/mL
collagenase/dispase (Roche Diagnostics, Mannheim, Germany)
and 0.1 mg/mL DNase type 1 (Sigma-Aldrich Corp.) and
incubated at 378C with stirring for 30 minutes three times.
The dispersed cells were filtered through a 100-lm cell strainer,
resuspended in complete medium, and centrifuged. The pellet
was washed with 1% BSA in PBS and was stimulated with RPMI
1640 supplemented with phorbol myristate acetate (50 ng/mL),
ionomycin (750 ng/mL), and Golgi plug (1 lg/mL) for 4 hours at
378C. Cells were blocked using purified anti-mouse CD16/32 (E-
bioscience, San Diego, CA, USA) for 15 minutes. After washing
with 1% BSA in PBS, cells were labeled with anti-mouse CD4-
efluor 605NC (E-bioscience), anti-mouse CD3-FITC (E-biosci-
ence), or anti-mouse ST2-percp-efluor 710 (E-bioscience) for 30
minutes at 48C. For intracellular staining, after perforating cell
membranes with BD cytofix/cytoperm, cells were labeled with
anti-mouse IL-5-phycoerythrin (PE) (E-bioscience) for 30 min-
utes at 48C. Flow cytometry analysis was performed using the
fluorescence-activated cell sorting (FACS) Calibur system.
Statistical Analyses
Data were analyzed with SPSS Windows version 20.0 (SPSS,
Inc., Chicago, IL, USA). All results are expressed as mean 6 SD.
The differences between experimental groups and control
group were analyzed using ANOVA with Bonferroni adjusted
post hoc comparison. In comparisons of cytokine levels with/
without allergen stimulation within the same group, a paired t-
test was used. Values of P < 0.05 were considered statistically
significant.
RESULTS
We confirmed the development of allergic conjunctivitis
induced by OVA and HDM antigens in our murine model,
TABLE 1. Clinical Data for Murine Model of Allergic Conjunctivitis
Symptoms
Grade (score)
Normal (0) Mild (1) Severe (2)
Behavior Normal Irritability Piloerection and squatting
Eye opening Normal Squinting Eye frowning
Discharge Absent Mild Prominent
Chemosis Absent Mild Severe
Hyperemia Absent Mild Severe
Eyelid edema Absent Mild Severe
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based on the clinical symptoms, elevated total IgE levels,
positive antigen-specific IgE levels, increased conjunctival
infiltration of mast cells and eosinophils, increased antigen-
specific lymphocyte proliferation, and in vitro increase in Th2
cytokine production after antigen stimulation.
Clinical Symptoms and Signs
Representative images of the early phase of ocular allergy are
shown in Figure 1. Significant increase of tearing or discharge
after ocular allergen challenge was seen in all experimental
groups, and mice exhibited clinical symptoms consistent with
allergic conjunctivitis, including eye frowning, agitation, and
lethargy/crouching, indicating severe ocular inflammation and
pain. Mice showed intermittent conjunctival hyperemia, but
no significant chemosis or eyelid edema. Clinical data are
summarized in Table 2. The mean clinical scores of the five
groups were 0, 7, 7, 6, and 6, respectively. None of the mice
had a score of 12, and three mice in group 2 had the highest
score (8). There was no significant difference in the clinical
scores among experimental groups (P > 0.05).
Total and HDM-Specific IgE in Serum
To exclude the effect of ALUM increasing IgE production, we
added the total IgE and specific IgE data of na¨ıve mice for
better comparison. Significantly elevated serum levels of total
IgE was found in both OVA and HDM groups compared with
the control group (Fig. 2A). Total IgE titer was detected highest
in the HDM (10 lg) group among HDM groups. As no HDM-
specific IgE standards exist, HDM-specific IgE values were
expressed in units of optical density (OD) at 450 nm. The
detection of HDM-specific IgE confirms that allergic conjunc-
tivitis is induced by HDM extract in this murine model (Fig.
2B).
Increased Antigen-Specific Lymphocyte
Proliferation and Th2-Type Cytokine Release After
Antigen Stimulation
T helper 2 cytokine (IL-4 and IL-5) production in supernatant
from cultured cervical lymphocytes after allergen stimulation
was significantly increased compared with that without
allergen stimulation in all immunized groups (Figs. 3A, 3B).
Interleukin-4 and IL-5 levels were significantly higher in
supernatant from immunized mice compared with that in
FIGURE 1. Clinical features of eyes in mice. (1) Before ocular allergen
challenge and (2) eye discharge (upper) and conjunctival redness
(lower) 20 minutes after ocular allergen challenge. (A) Phosphate-
buffered saline challenge in control mice. (B) After ocular challenge
with 5% OVA (OVA group). (C–E) After challenge with 10% HDM in
HDM 10, 100, and 500 lg groups, respectively. (3) Behavior change
after ocular allergen challenge. (A) Score 0, normal. (B) Score 2, eye
frowning and lethargy/body squatting with piloerection reflect ocular
discomfort and severe ocular inflammation following ocular allergen
challenge.
FIGURE 2. Levels of total and HDM-specific IgE. All serum samples were diluted 1:10 before measurement of IgE levels, and all data represent the
mean 6 SD. To exclude the effect of ALUM increasing IgE production, we added the total IgE and specific IgE data of na¨ıve mouse as an additional
negative control for comparison. As no HDM-specific IgE standards exist, HDM-specific IgE values were expressed in units of optical density (OD) at
450 nm. (A) Comparison of total IgE titers in serum. Total IgE was significantly increased in all allergen-sensitized groups compared with that in the
control group. (B) The detection of HDM-specific IgE confirms that allergic conjunctivitis is induced by HDM extract in this murine model. *P <
0.05; **P < 0.01; and ***P < 0.001, all compared with the control group (ANOVA with Bonferroni-adjusted post hoc comparison).




10 lg 100 lg 500 lg
Behavior 0 2 2 2 2
Eye opening 0 2 2 2 2
Discharge 0 2 2 2 1
Chemosis 0 0 0 0 0
Hyperemia 0 1 1 0 1
Eyelid edema 0 0 0 0 0
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control mice after allergen stimulation. Interleukin-4 release
from cervical lymphocytes with HDM stimulation was not
significantly different among HDM groups; however, IL-5
release was significantly increased in the HDM (10 lg) group
compared with other HDM groups.
T helper 1–type cytokine (IL-2 and IFN-c) release was
significantly increased in cultured cervical lymphocytes with
allergen stimulation compared with that without allergen
stimulation (OVA and HDM [500 lg] in Figs. 3C and 3D,
respectively). Cytokine release of TNF-a, IFN-c, and IL-2 from
cultured cervical lymphocytes with antigen stimulation did not
differ significantly between control and allergen-immunized
groups (Figs. 3C–3E).
T-cell and CD4þ T-cell lines from cervical lymph nodes of all
immune-sensitized mice groups proliferated considerably in
the in vitro cultures with specific allergen, OVA or HDM, as
assessed using the BrdU assay (Fig. 4). These findings imply
that OVA- or HDM-immunized mice have allergen-specific T
lymphocytes and CD4þ T cells in their cervical lymph nodes
and can secrete significantly higher amounts of Th2 cytokines
on allergen challenge.
Histopathologic Analysis
Histopathologic analysis indicated significant increased con-
junctival infiltration of eosinophils and mast cells in allergen-
sensitized mice compared with control mice (Fig. 5). However,
there was no significant difference in eosinophil or mast cell
infiltration into conjunctiva among the HDM-immunized
groups.
Quantitative Analysis of CD4þ T Lymphocytes in
Conjunctiva
When CD4þ T lymphocytes from conjunctiva were stained for
membrane-bounded ST2, an increase of conjunctival
ST2þCD4þ T (Th2) lymphocytes in allergen-immunized mice,
concomitant with increased intracellular IL-5, was seen,
compared to that in control mice (Fig. 6).
DISCUSSION
In this study, we developed a new murine model of allergic
conjunctivitis induced by D. pteronyssinus using BALB/c mice.
In our laboratory, we tried to reproduce murine models with
allergic conjunctivitis induced by HDM according to previously
reported protocols.14,15 However, we could not confirm
clinical signs and laboratory data of allergic conjunctivitis as
shown in the OVA-stimulated induction of allergic conjuncti-
vitis in previous murine models.26,28 In our preliminary
studies, we found that BALB/c mice are more suitable for the
allergic model than C57BL/6 mice, based on BALB/c mice
tending to a more Th2-like profile (data not shown).15
Moreover, the cervical lymph node was more suitable and
specific than the spleen in estimating and representing the
systemic immune response in allergic conjunctivitis, akin to
the localized inflammation seen in human allergic conjuncti-
vitis. Because the lymph from bulbar conjunctiva and eyelid
contains soluble antigens and arrives at the cervical lymph
nodes via afferent lymphatic vessels, cervical lymph nodes
containing T helper cells against the allergens reflect ocular
allergy activity well. Then, we developed an animal model of
FIGURE 3. Measurement of cytokine levels in the supernatant from cervical lymphocyte cultures with/without allergen stimulation. Cervical
lymphocytes from mice in the five groups (control, OVA, and HDM [10, 100, and 500 lg]) were cultured in vitro, and the levels of indicated
cytokines in the supernatant were measured using ELISA. Data represent the mean 6 SD of five independent trials. *P < 0.05; **P < 0.01; and ***P <
0.001, all compared with the control group. Note that the cytokine titers are significantly higher in the immunized groups compared with that in the
control group, with allergen stimulation. P < 0.05, in comparisons of cytokine levels with/without allergen stimulation within the same group. T
helper 2 cytokine (IL-4 and 5) release was significantly higher in all immunized groups compared with in the control group in the in vitro culture
with allergen. T helper 1 cytokine (IL-2 and IFN-c) release was significantly increased in the OVA and HDM 500 lg group after allergen stimulation.
Tumor necrosis factor-a, one of the inflammation cytokines, was significantly increased in control and HDM 100 lg and 500 lg groups after allergen
stimulation. However, there is no difference in cytokine titers (TNF-a, IL-2, and IFN-c) among experimental groups.
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FIGURE 4. Quantitative cell cycle analysis of antigen-specific lymphocytes and antigen-specific CD4þ T lymphocytes in cultures of cervical lymph
node lymphocytes with/without antigen stimulation (BrdU ELISA assay). Bromodeoxyuridine is incorporated into newly synthesized DNA by cells
entering and progressing through the S (DNA replication) phase of the cell cycle. In the OVA-immunized group, the cervical lymphocyte population
of S-phase cells was increased in in vitro culture with OVA (6.2% vs. 9.4%). In all HDM-immunized mice, S-phase (13.2%, 11.5%, and 12.5% for the 10,
100, and 500 lg groups, respectively) of cervical lymphocyte population was significantly increased compared with 4.7%, 3.2%, and 3.3% of the
population (no stimulation), respectively, after HDM stimulation. These demonstrated that antigen-specific lymphocytes in cervical lymph nodes of
all immunized groups are actively proliferated after allergen stimulation. Similarly, the frequency of CD4þ T cells that incorporated BrdU (S-phase)
was 4.3% without OVA stimulation but was 5.2% with OVA stimulation in the cervical lymphocytes culture from the OVA-immunized group. The
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allergic conjunctivitis using D. pteronyssinus extract, a
common perennial allergy-causing HDM allergen, in BALB/c
mice.
Here, we provide strong evidence for the development of
allergic conjunctivitis induced by D. pteronyssinus extract,
corresponding to the early and late phases of allergic reaction,
similar to that observed in human perennial and OVA-based
models of allergic conjunctivitis.28,29 Clinically, we observed
that mice squatted with piloerection and presented with
discharge, conjunctival hyperemia, lid swelling, and eye
frowning. In addition to ocular symptoms, there was also a
systemic immune response induced by the HDM extract,
characterized by increased total and specific IgE titers in serum
and increased proliferation of HDM-specific T lymphocytes and
HDM-specific T helper cells in cervical lymph nodes, along
with the production of IL-4 and IL-5.
In this study, systemic immunization using 10 lg HDM
extract induced a more significant increase in Th2 cytokine
and IgE than with other HDM doses. The allergic reaction
induced with 500 lg HDM extract for systemic immunization
in our study was greater than that observed at 5 lg HDM
extract used by Giavina-Bianchi et al.15
Liu et al.14 developed a mouse model of allergic conjunc-
tivitis using lyophilized D. farinae polypides extracts at 3.86
kUA/L total potency. The immunization dose and schedule
used by Liu et al.14 requires a considerable expense for
performing experiments in animal models of allergic conjunc-
tivitis because the cost of HDM allergen is expensive.
Therefore, the optimal dose for immunization described in
our study, wherein a lower total amount of HDM extract
induces maximal allergic reaction, is a more economical
solution for future immunologic and therapeutic studies of
allergic conjunctivitis in a murine model.
The culture of cervical lymphocytes of immunized mice
with allergen stimulation significantly increased the release of
IL-4 and IL-5. Moreover, in the OVA and HDM (500 lg) groups,
FIGURE 5. Histograms showing the relative numbers of eosinophils and mast cells per slide in conjunctiva .The conjunctival samples were isolated
from mice 24 hours after the final challenge, and histopathologic analysis was performed as described in Materials and Methods. (A) Quantitative
analysis of eosinophil infiltration into conjunctiva. (B) Quantitative analysis of mast cell infiltration into the conjunctiva. Data represent the mean 6
SD of five independent trials. *P < 0.05, compared with mice in the control group (ANOVA with Bonferroni-adjusted post hoc comparison).
frequency of CD4þ T cells in S-phase was 5.02%, 1.37%, and 2.01% without HDM stimulation but was increased to 11.7%, 3.33%, and 15.5%,
respectively, with HDM stimulation in the HDM-immunized groups (10, 100, and 500 lg). These demonstrated that antigen-specific CD4þ
lymphocytes in cervical lymph nodes of all immunized groups are actively proliferated after allergen stimulation.
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allergen-stimulated Th1 cytokine release was also higher;
however, it was not significant compared with that in the
control group. The interaction between Th1 and Th2 cytokines
may account for the lower total IgE in serum in the HDM (500
lg) group compared with that in other HDM groups. The
analysis of lymphocyte proliferation demonstrates the exis-
tence of antigen-specific lymphocytes and antigen-specific
CD4þ T-cell lines in cervical lymph nodes in all immunized
mice. The increase of eosinophils and mast cells in conjunctiva
may be interpreted based on the fact that antigen challenge of
conjunctiva stimulates migration of mature DCs to the cervical
lymph node, activating a Th2 cell–mediated response and B-
cell proliferation, which then results in conjunctival mast cell
activation and recruitment of mast cells and eosinophils to
conjunctiva.4,5
Recent studies have highlighted the IL-33–ST2 interaction
pathway as a potential target in allergic disease.18–24 ST2 is an
orphan receptor, an IL-1 receptor family member that is also
known to be expressed on murine Th2 and mast cells and
binds with the ligand IL-33.18 CD4þ T cells become ST2þ on
repeated antigenic stimulation under Th2-polarizing condi-
tions, but in an IL-4–independent mechanism, and the cross-
linking of IL-33 and ST2 induces proliferation and cytokine
production in Th2, but not Th1, cells.18 IL-33 is released by
epithelial barrier tissue damage induced by different environ-
mental stimuli such as airborne allergens, viruses, and air
pollutants, and its cross-linking with ST2 on Th2 lymphocytes,
mast cells, and eosinophils induces Th2 cytokine release
(especially IL-5 and IL-13), which, in turn, plays an important
role in allergic dermatitis, asthma, rhinitis, and allergic
conjunctivitis.18–22 In our murine model of allergic conjuncti-
vitis, ST2 expression on the membranes of conjunctival CD4þT
lymphocytes was increased in OVA- or HDM-immunized mice.
The capacity for IL-5 production was especially increased in
conjunctival CD4þST2þ T lymphocytes of HDM-immunized
mice. These data suggest that activated conjunctival CD4þ T
lymphocytes express ST2 after repeated ocular allergen
challenge, and the subsequent increase in intracellular IL-5
may play a critical role in recruiting eosinophil into conjunctiva
in mice with HDM-induced allergic conjunctivitis. This
suggests that the ST2–IL-33 interaction, an IL-4–independent
pathway, may contribute to the development of the murine
model with HDM allergic conjunctivitis. This mechanism
differs from the classical allergen-specific IgE-mediated allergic
immunologic pathway. Further studies that focus on the
association between conjunctival CD4þST2þ T lymphocytes
and release of other Th2 cytokines, such as IL-4,5, and9 and
IL-13, and that investigate the IL-33–ST2 interaction in the
conjunctiva of mice with allergic conjunctivitis may help
identify new therapeutic targets in HDM allergic conjunctivitis.
In the acute phase of allergic conjunctivitis, type 1
hypersensitivity by mast cells is a main mechanism of allergic
response, but in the chronic phase of allergic conjunctivitis or
perennial allergic conjunctivitis, eosinophils and mast cells
play a main role in making the allergic response. Therefore,
this model, which showed increased eosinophils and mast cells
in the conjunctiva and HDM-specific Th cells in cervical lymph
nodes, can be used for future models of allergic conjunctivitis
induced by HDM. The use of a mast cell stabilizer, steroid
(immune inhibitor), and the lubricant as artificial tear (to
reduce conjunctiva mucosal damage) can be helpful to reduce
inflammatory response from various immune modulating cells
from mast cells, eosinophils, local activated Th2 (CD4þST2þ)
cells in conjunctiva, and specific-allergen Th cells in cervical
lymph nodes.
CONCLUSIONS
We expect that the murine model and findings described in
this report will be applicable for future studies of HDM allergic
conjunctivitis. We found that the effective and optimal dose of
systemic immunization in this model was 10 lg HDM extract.
Data from the clinical, histopathologic, and biochemical
analyses support the development of allergic conjunctivitis in
our murine model, akin to that induced by OVA and observed
FIGURE 6. Analysis of intracellular IL-5 in CD4þST2þ T lymphocytes. (A) Increase of ST2 expression in conjunctival CD4þ T cells in OVA and HDM
groups compared with that in the control group. (B) The proportion of conjunctival CD4þST2þT cells with intracellular IL-5 is increased in allergen-
immunized mice with allergic conjunctivitis compared with that in the control group. ST2 expression, as well as the capacity of secreting IL-5, of
conjunctival CD4þ T cells is increased in HDM (10 lg)–immunized mice compared with that in OVA-immunized mice.
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in human allergic conjunctivitis. These days, the incidence of
allergic conjunctivitis induced by HDMs and air pollutants like
fine dust is rising. In particular, our data support further
analysis of strategies focused on suppression of ST2 expression
in conjunctival CD4þ T lymphocytes or mast cells, attenuation
of IL-33 release from conjunctival epithelial cells after ocular
allergen challenge, or blocking induction of their cross-linking,
as novel avenues of research in allergic conjunctivitis
treatment.
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